Issue 9/2020
Content (13 Articles)
DEGRO practical guideline for partial-breast irradiation
V. Strnad, D. Krug, F. Sedlmayer, M. D. Piroth, W. Budach, R. Baumann, P. Feyer, M. N. Duma, W. Haase, W. Harms, T. Hehr, R. Fietkau, J. Dunst, R. Sauer
Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer
Jin Meng, Wenzhi Huang, Xin Mei, Xiaoli Yu, Ziqiang Pan, Jinli Ma, Xuejun Ma, Jiayi Chen, Xiaomao Guo, Zhaozhi Yang
Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
Kai J. Borm, Markus Oechsner, Mathias Düsberg, Gabriel Buschner, Weber Wolfgang, Stephanie E. Combs, Marciana N. Duma
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Matthias Paireder, Gerd Jomrich, Ivan Kristo, Reza Asari, Erwin Rieder, Andrea Beer, Aysegül Ilhan-Mutlu, Matthias Preusser, Rainer Schmid, Sebastian F. Schoppmann
Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients
Stefan Münch, Lisa Marr, Benedikt Feuerecker, Hendrik Dapper, Rickmer Braren, Stephanie E. Combs, Marciana-Nona Duma
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
Dirk Rades, Tobias Bartscht, Peter Hunold, Heinz Schmidberger, Laila König, Jürgen Debus, Claus Belka, Nils Homann, Patrick Spillner, Cordula Petersen, Thomas Kuhnt, Rainer Fietkau, Karsten Ridwelski, Kerstin Karcher-Kilian, Anne Kranich, Sofia Männikkö, Steven E. Schild, Annett Maderer, Markus Moehler
Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses?
Meltem Kirli Bolukbas, Sibel Karaca
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
Luca Nicosia, Francesco Cuccia, Rosario Mazzola, Francesco Ricchetti, Vanessa Figlia, Niccolò Giaj-Levra, Michele Rigo, Davide Tomasini, Nadia Pasinetti, Stefanie Corradini, Ruggero Ruggieri, Filippo Alongi
Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy
Yvonne Lorat, Jochen Fleckenstein, Patric Görlinger, Christian Rübe, Claudia E. Rübe
Superoxiddismutasemimetikum (GC4419) vs. Placebo zur Reduktion von schweren oralen Mukositiden infolge simultaner Radiochemotherapie mit Cisplatin bei Kopf-Hals-Tumoren: randomisierte, doppelblinde Phase-IIb-Studie
Irenäus A. Adamietz
Adjuvante Chemotherapie in der Behandlung der Urothelkarzinome des oberen Harntraktes
Lea Pape, Johanna Richter, Jürgen Dunst
Pembrolizumab in der neoadjuvanten Behandlung des frühen triple-negativen Mammakarzinoms
Friederike Dierks, Elisabeth Pietsch, Jürgen Dunst
Stellenwert der Hippocampusschonung bei therapeutischer Ganzhirnbestrahlung
Michael Mayinger, Nicolaus Andratschke